VSee Health Inc. Faces Nasdaq Delisting; Plans to Request Reconsideration Amid Trading Suspension

Reuters
Aug 11
VSee Health Inc. Faces Nasdaq Delisting; Plans to Request Reconsideration Amid Trading Suspension

San Jose, CA - August 8, 2025 - VSee Health, Inc. has announced that the Nasdaq Stock Market has decided to delist the company due to delayed filings of its Annual Report and Quarterly Report. Trading of VSee Health's common stock and warrants is set to be suspended on Nasdaq starting August 14, 2025. In response, the company plans to request reconsideration from the Nasdaq Listing and Hearing Review Council. Meanwhile, VSee Health's securities are expected to begin trading on the OTC Markets under the symbols "VSEE" and "VSEEW" from August 14, 2025. The company remains focused on meeting compliance standards and will update shareholders on significant developments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-075813), on August 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10